Home · Peptides · Livagen
THE PEPTIDE APP FIELD GUIDE · Healing SERIES FIELD SPECIMEN
Healing CATEGORY

Livagen

THE LIVER REVITALIZER

Lys-Glu-Asp-Ala

Livagen is a synthetic tetrapeptide bioregulator that can actually interact with your DNA to influence gene expression. It's been shown to activate genes in immune cells that may have become "silenced" with age. It may help restore youthful immune function and cellular repair capacity.

Livagen
Livagen
Livagen

Livagen Evidence Snapshot

How these guides are reviewed
REGULATORY STATUS

Not FDA approved · research use only

DOSING GUIDANCE

Reviewed by our clinical team

LINKED EVIDENCE

1 research sources

CONTENT UPDATED

Aug 28, 2026

Dose and schedule recommendations shown below come from The Peptide App Clinical Team. Research links are provided so readers can inspect the supporting evidence directly. Review the sources.

Quick Answers About Livagen

◆

Is Livagen FDA approved?

No. This profile records Livagen as not FDA approved and for research use only.

MORE CONTEXT ›

Review the regulatory and source details on this page for the current context.

◆

What dose does The Peptide App Clinical Team recommend for Livagen?

Dose: 10-20 mg daily (injection or oral).

MORE CONTEXT ›

Schedule: daily. Cycle: 10-20 days on, 3-6 months break. This is clinical-team guidance for reference and does not replace individualized instructions from a licensed clinician.

◆

What research supports this Livagen guide?

This guide links to 1 curated or current research sources.

MORE CONTEXT ›

Open the research section to inspect the source titles, publication details, study types, and available abstracts directly.

Studied Effects & Mechanisms

Gene Activation

Interacts with DNA to reactivate silenced genes in lymphocytes

Immune Enhancement

Boosts lymphocyte function and immune resilience

Cellular Repair

Promotes tissue regeneration and cell renewal

Anti-Inflammatory

Reduces oxidative stress and inflammatory markers

Anyone recovering from illness
Those interested in epigenetic modulation
People with weakened immunity due to age

Livagen Research

Live research temporarily unavailable

The live research feed did not return papers for this page. The curated references below remain available for crawlable source context.